Connect with us

Health

COVID-19: FG okays 5 states, FCT for WHO’s clinical trials ……Advises States to Liaise With Catholic Bishops For Isolation Spaces

Published

on

COVID-19: FG okays 5 states, FCT for WHO’s clinical trial
•Warns patients against attacking health workers
•To subject ‘Madagascar’s cure’ to analysis; over 27,000 tests conducted so far
•We’re not aware, but clinical trial is a normal process — NMA President

The Federal Government has enrolled the Federal Capital Territory, FCT as well as Lagos, Ogun, Kano, Kaduna and Sokoto states in the “solidarity trials”, an international clinical trial to help find a cure for COVID-19 being spearheaded by the World Health Organization, WHO.

The government also warned COVID-19 patients in its isolation and treatment centres against attacking doctors and other healthcare workers who are catering for their medical needs, describing such actions as inhuman, unacceptable and reprehensible.

It also said it has conducted over 27,000 tests so far, while about 600 Nigerians in diaspora had been evacuated and are now in isolation.

The government equally confirmed that it has reached out to Madagascar for its elixir named “Covid Organic,” but said the product will be subjected to scientific analysis to ascertain its genuineness and perhaps begin its local production.

This is even as the National Human Rights Commission, NHRC, announced yesterday that it received a total of 104 complaints on rights violations from 27 states across the country.

…….WHO solidarity trials

Speaking at yesterday’s briefing of the Presidential Task Force, PTF, on COVID-19, Minister of Health, Dr Osagie Ehanire, listed the states that would be participating in the trials.

The solidarity trial, which is an international clinical trial to help find an effective treatment for COVID-19, was launched by the WHO and partners.

More than 100 countries have joined the solidarity trial and to date, over 1,200 patients have been randomized from the first five countries to evaluate the safety and efficacy of full drug and drug combinations.

WHO had announced that Nigeria had recently indicated its readiness to join the trials.

Giving an update on the trials, the minister said: “The Federal Government is cooperating with WHO on treatment regimen solidarity trial, with the following states enrolled:  Lagos, FCT, Ogun, Kaduna, Sokoto and Kano.”

………We are not aware but it is a normal scientific process — NMA

Contacted on the issue, President of the Nigerian Medical Association, NMA, Dr Francis Faduyile said although the NMA was not aware of the trial, the process was a scientific procedure to get drugs and vaccines approved.

“We have been involved in other clinical trials not only on COVID-19 but in drug formulations.   It is a normal thing in science and it does not mean that the Federal Government wants to use Nigerians as guinea pigs. They must have passed through a lot of processes before they want to do trials.

“It is a normal scientific process of getting drugs approved as well as getting vaccines approved. We are not aware of this one the Federal government is planning but it is a normal process.”

…….Attack on health workers

Chairman of the PTF and Secretary to the Government of the Federation SGF, Mr Boss Mustapha, said most of the demands made by patients are such that health workers are not in a position to meet.

There had been reports of COVID-19 patients attacking health workers and asking for improved welfare or be released.

He said: “The PTF has also continued to receive, rather sadly, reports about challenges facing the front-line health workers. They have received threat to lives, experienced detention by patients they are actually nursing to health and suffered other forms of harassment.

An Isolation centre


“Let me underscore the fact that these front-line workers constantly put their lives on the line to make sure persons infected are provided with the best care possible to enable them become healthy citizens again.

“It is, therefore, inhuman and unacceptable that patients engage in acts of locking them up and making demands that these front-line officers, most of the time do not have the capacity to address. The PTF views such behaviour as reprehensible and should be deprecated. We call on all state governments to take this up appropriately.”

He added that the PTF was identifying and assessing all low to medium and high burden areas, with a view to assessing and modifying its strategy to strengthen community ownership in the national response.

……States to liaise with Catholic Bishops

The Federal Government also asked states to liaise with Catholic Bishops in their areas in order to access more spaces for isolation of COVID-19 cases.

He said it would soon be impossible for state capitals to contend with the number that would be thrown at them, hence the need to accept every offer of bed space from good-spirited individuals and organizations.

“We wish to confirm that states have been encouraged strongly to set up isolation centres, wards (including ICU) with a minimum of 300 beds each. This will help accommodate levels 1 & 2 cases. “However, with the increase in numbers, we are beginning to experience a shortage of bed spaces in the isolation centres, especially in the high burden areas.

“We are conscious of the need to take care of different categories of persons e.g. people living with disabilities, terminal conditions and other underlying factors/co-morbidities.

“As part of efforts to support states in the establishment of isolation and treatment centres, I wish to remind our governors that the Catholic Bishops Conference has volunteered all the 425 hospitals and clinics nationwide for adaptation and use as isolation centres.

“Governors are encouraged to please approach Catholic Bishops in their states to access these facilities,” the SGF said.

…..Madagascar’s cure to be tested

Madagascar’s CovidOrganic


The SGF said the product which is currently in Guinea-Bissau, would soon be freighted to Nigeria and subjected to all necessary validations before usage.

He said: “With respect to the Madagascar syrup, it has been freighted to Guinea-Bissau by the President of Madagascar. Certain allocations have been made to different countries. We have an indication of the quantity that has been allocated to Nigeria and we are supposed to make arrangements to freight it out of Guinea-Bissau to Nigeria.

“I have received instructions from Mr President to make arrangements to freight it home with a clear instruction that I should subject it to the validation process similar to what would happen to any other medicine or syrup or vaccine that is discovered or created internally.

“So, it will be subjected to the same process before it is put into any form of use. There will be no exception on that.’’

Speaking in the same vein, the Minister of Health, Dr Osagie Ehanire, said Nigeria would analyze the syrup to see if it could be reproduced here.

He said: “We have a promise of being able to get samples of the herb or botanical product for analysis and also probably use that opportunity to speak with the health authorities there, particularly the scientific community on how they use it.

“But obviously, to also give back to the research community here to examine and see what they can do with it.

“We understand that it is something called ‘Artemisia Annua’ which also grows here but we will like to, if we get that sample, compare it with the strain here, whether they are exactly identical or whether they are two different strains and see what properties it has and subjected to further analysis to find out what works there, how it works and the use in getting a cure.

“Obviously, countries in the world are interested in finding a cure and we are not different. So, we are looking at all possibilities, all options, all promises that are made, we examine them, and before we give them to our people, we make sure they are actually safe and that they work.”

On the number of tests conducted so far, the minister said: “At the end of yesterday (Sunday), Nigeria has ramped up testing by 1,127 to a total of 27,078 tests, which yielded 4,399 cases in 35 states, with a gender ratio of 70 to 30 percent for men and women.

“778 persons have been discharged home and we have sadly recorded 143 fatalities, giving a case fatality rate of 3%.

“Senior management of the Federal Ministry of Health and clinical case managers in our hospitals this morning participated in a multinational teleconference with Chinese medical and academic experts in Beijing, where much insight was gained into the treatment strategy of China and other matters of common interest were discussed. The learning from this intervention is invaluable in reexamining our methods,” he added.

……New 500-bed space in Abuja

The Federal Capital Territory Administration on its part, has unveiled a 500-bed capacity isolation centre in the Idu district of the territory.

FCT Minister, Malam Muhammad Musa Bello, while commissioning the isolation centre, appealed to residents to take responsibility and follow all the laid down protocols by health experts to halt the spread of coronavirus.

…..Rights violations

The SGF also announced that it had received a letter from the National Human Rights Commission, NHRC, detailing incidences of rights violation by security operatives enforcing the COVID-19 restrictions.

Executive Secretary of the commission, Tony Ojukwu, had in a report, documented the various thematic areas in which the violations occurred, the nature of the violations, the disaggregated data on state reported violations, the agencies of government responsible for the violations as well as the response/action taken to remedy the violations.

The violations occurred between April 13 and May 4, 2020.

Ojukwu listed the states as Abia, Adamawa; Akwa Ibom; Kano; Jigawa; Cross Rivers; Ebonyi; Edo; Enugu; Ekiti; Delta; Imo; Lagos; Nasarawa; Niger; Ogun; Osun; Borno; Bayelsa; Kogi; Benue; Anambra; Kaduna; Gombe; Zamfara and Rivers.

According to the NHRC report, Enugu State has the highest recorded cases with 13 incidents, followed by Imo State with 12 incidents; Akwa Ibom and Nasarawa states recorded 10 incidents each, while Delta and Abia states recorded nine and seven incidents respectively.

“Lagos State recorded five cases, while FCT and Benue state recorded four cases each, followed by Niger, Zamfara, Osun and Rivers states with three incidents each. Anambra, Jigawa, Bayelsa and Edo States recorded two incidents each; while Ogun, Kogi, Borno, Gombe, Kaduna, Adamawa, Ebonyi, Kano, Cross River and Ekiti states recorded one incident each.

“The complaints of human rights violations were received and documented in the areas of extra-judicial killings, violation of right to freedom of movement, unlawful arrest and detention, seizure/confiscation of properties, sexual and gender based violence, SGBV, torture, inhumane and degrading treatment and extortion.

“There were 11 documented incidents of extra-judicial killing leading to 11 deaths. Out of this number, four deaths were recorded in Abia state alone. Delta state recorded two deaths, while Niger, Jigawa, Lagos, Anambra and Rivers states recorded one death each.

“The report further shows that out of the 11 deaths, the Nigeria Police Force was responsible for seven deaths, while the Nigeria Security and Civil Defence Corps (NSCDC), non-state actors and the Abia State Task Force on COVID-19 were responsible for one death each.

“Investigation is still on-going as at the time of the report to unravel the perpetrator of the extra-judicial killing that occurred in Jigawa State,’’ Ojukwu said.

The report also showed other types of violations recorded within the period to include 34 incidents of torture, inhumane and degrading treatment, 14 incidents of violation of right to freedom of movement, unlawful arrest and detention, 11 incidents of seizure/confiscation of properties, 19 incidents of extortion and 15 incidents of Sexual and Gender Based Violence, SGBV.

He added: “The report finds that the Nigeria Police Force accounted for 59.6 per cent of the total cases of violations, followed by non-state actors that is mostly private individuals in SGBV related cases which accounted for 18.3 per cent of the total cases.

“The various task forces on enforcement of COVID-19 regulations across the states accounted for 10.5 percent of the total cases, while the Nigeria Army and the Nigeria Security and Civil Defence Corps, NSCDC, accounted for 7.7 per cent and 1.9 per cent respectively.

“The Department of State Services, DSS, also accounted for one percent of the total cases, while a perpetrator representing the other one percent is yet to be determined at the time of this report.

Continue Reading

Health

Mpox: What You Need to know

Published

on

WHO image

 

Mpox

Mpox, formerly called monkeypox, is a rare disease similar to smallpox caused by a virus. It’s found mostly in areas of Africa, but has been seen in other regions of the world. It causes flu-like symptoms such as fever and chills, and a rash that can take weeks to clear. There’s no proven treatment for mpox, but it usually goes away on its own.

What is Mpox?

Mpox (previously known as monkeypox) is a rare disease caused by a virus. It leads to rashes and flu-like symptoms. Like the better-known virus that causes smallpox, it’s a member of the genus Orthopoxvirus.

Mpox spreads through close contact with someone who’s infected. You can also get it from an infected animal.

There are two known types (clades) of mpox virus — one that originated in Central Africa (Clade I) and one that originated in West Africa (Clade II). The current world outbreak (2022 to 2023) is caused by Clade IIb, a subtype of the less severe West African clade.

How common is mpox?

Mpox is rare. But the number of cases is increasing in Africa, as well as in regions that haven’t seen these infections before.

Where else is mpox found?

For decades, mpox was mostly seen in Africa. But it’s occasionally found in other countries, including the United States.

In the summer of 2021, a case of mpox was found in a U.S. resident who had traveled from Nigeria to the United States. Then, 2022 brought outbreaks to regions outside of Africa, including Europe, the Americas and Australia.

Who does mpox affect?

Anyone can get mpox. In Africa, most cases are among children under 15 years old. Outside of Africa, the disease appears to be more common in men who have sex with men (MSM), but there are numerous cases in people who don’t fall into that category.

Mpox (monkeypox) rash can be painful, with spots that change over time before scabbing and falling off.

What are the signs and symptoms of mpox?

After exposure, it may be several days to a few weeks before you develop symptoms. Signs of mpox include:

Fever.

Rash.

Swollen lymph nodes.

Chills.

Headache.

Muscle aches.

Fatigue.

The rash starts as flat, red bumps, which can be painful. Those bumps turn into blisters, which fill with pus. Eventually, the blisters crust over and fall off. The whole process can last two to four weeks. You can get sores on your mouth, face, hands, feet, penis, vagina or anus.

Not everyone with mpox develops all the symptoms. Different ways you might experience symptoms include:

* Only a rash (no other symptoms), or other symptoms developing later.

* Flu-like symptoms, then a rash. Some people don’t get a rash at all.

* A rash can be widespread, but some people only a have few bumps or blisters.

* You can have mpox and not know it. Even if you don’t show many signs of infection, it’s possible that you can spread still spread it to others through prolonged close contact.

How do you catch mpox?

Mpox spreads when you come into contact with an animal or a person infected with the virus.

Person-to-person spread (transmission) occurs when you come in contact with the sores, scabs, respiratory droplets or oral fluids of a person who’s infected, usually through close, intimate situations like cuddling, kissing or sex. Research is ongoing, but experts aren’t sure if the virus is transmitted through semen or vaginal fluids.

Animal-to-person transmission occurs through broken skin, like from bites or scratches, or through direct contact with an infected animal’s blood, bodily fluids or pox lesions (sores).

You can also get mpox by coming into contact with recently contaminated materials like clothing, bedding and other linens used by a person or animal who’s infected.iagnosis and Tests

How is mpox diagnosed?

Because mpox is rare, a healthcare provider may first suspect other rash illnesses, such as measles or chickenpox. But swollen lymph nodes usually distinguish mpox from other poxes.

To diagnose mpox, your healthcare provider takes a tissue sample from an open sore (lesion). Then, they send it to a lab for polymerase chain reaction (PCR) testing (genetic fingerprinting). You may also need to give a blood sample to check for the mpox virus or antibodies your immune system makes.

Management and Treatment: Is mpox curable?

Mpox is usually a self-limited disease (gets better without treatment) with symptoms lasting from two to four weeks. Following diagnosis, your healthcare provider will monitor your condition and try to relieve your symptoms, prevent dehydration and give you antibiotics to treat secondary bacterial infections if they develop.

How is mpox treated?

There aren’t any currently approved antiviral treatments for mpox. If you’re very sick, your provider might prescribe antiviral drugs like cidofovir or tecovirimat. These drugs are approved to treat other viral infections (like smallpox), but researchers need to learn more about how well they work for mpox.

Prevention: How do you prevent mpox?

If you’re at risk for mpox, getting vaccinated helps stop the spread. Other forms of prevention include decreasing human contact with infected animals and limiting person-to-person spread.

Mpox vaccines

Vaccines developed for smallpox also provide protection against mpox. Mpox vaccines are currently only recommended for people who’ve been exposed to, or are likely to be exposed to, mpox. You might be at higher risk of exposure if:

* You’ve been in close contact with someone with mpox.

* Someone you’ve had sex with in the past two weeks has been diagnosed with mpox.

* You’ve had sex at a sex club, bathhouse or other commercial sex venue in the past six months.

* You’ve had sex at an event or location where mpox was spreading.

* You have a sex partner who’s been in any of the above situations.

* You expect to be in one of the above situations.

* If you’re a man who has sex with men, a transgender person or a nonbinary person, you may also be at risk if you’ve:

Been diagnosed with one or more sexually transmitted infections (STIs) in the past six months. This includes acute HIV, gonorrhea, syphilis, chancroid or chlamydia.

Had sex with more than one person in the past six months.

It’s important to get vaccinated before or as soon as possible after exposure. Talk to a healthcare provider if you’re unsure if you should get vaccinated. If you’d like to get your shot in a more concealed location on your body, your provider can give it to you in your shoulder blade instead of your forearm.

Other ways to prevent mpox

In addition to vaccines, other ways to help prevent the spread of mpox include:

* Avoiding contact with infected animals (especially sick or dead animals).

* Avoiding contact with bedding and other materials contaminated with the virus.

* Thoroughly cooking all foods that contain animal meat or parts.

* Washing your hands frequently with soap and water.

* Avoiding contact with people who may be infected with the virus.

* Practicing safe sex, including the use of condoms and dental dams.

* Wearing a mask that covers your mouth and nose when around others.

* Cleaning and disinfecting frequently touched surfaces.

* Using personal protective equipment (PPE) when caring for people infected with the virus.

Outlook / Prognosi: How long does mpox last?

Mpox normally takes about two to four weeks to run its course. If you’re exposed to mpox, your provider will monitor you until the rash resolves.

Is mpox fatal?

It’s rare, but mpox is sometimes fatal. Mpox can also lead to problems (complications) like pneumonia and infections in your brain (encephalitis) or eyes, which can be life-threatening.

 

Living With: How do I take care of myself?

If you have mpox symptoms, there are over-the-counter (OTC) medications that can help you feel better, including:

Pain relievers and fever reducers. Medicines like ibuprofen (Advil®, Motrin®) and acetaminophen (Tylenol®) can help relieve your symptoms.

Oatmeal baths. Soaking in a warm bath with colloidal oatmeal can relieve the dry, itchy feeling that comes with skin rashes.

Isolate yourself if you’re infected. Avoid contact with others until all of your lesions have scabbed.

Cover single or local ulcers or sores. Use gauze or bandages to limit the spread to others and the environment.

Take good care. It’s important to stay home and rest when you’re sick, wear a mask around others and drink plenty of fluids.

Avoid contact with pets (especially rodents).

When should I see my healthcare provider?

Call your healthcare provider if you:

Feel sick with fever, aches or swollen lymph nodes.

Have a new rash or sores.

Have been in close contact with a person who’s infected.

When should I go to the ER?

Seek medical care if you develop the following symptoms:

Trouble breathing.

New or worsening chest pain.

Stiff neck.

Confusion or difficulty thinking clearly.

Difficulty speaking or moving.

Loss of consciousness.

Seizures.

Additional Common Questions

Why don’t we call it monkeypox anymore? Who changed the name?

The name monkeypox carries stigmas with it, including those about race. The World Health Organization (WHO) changed the name to mpox in November of 2022.

 

What is the difference: Mpox vs. chickenpox

Although they both cause skin rashes, different viruses cause mpox and chickenpox. Mpox is an orthopoxvirus, while chickenpox is a herpes virus. Both viruses can spread through skin-to-skin or prolonged face-to-face contact, but chickenpox is very contagious and spreads more easily than mpox. People with mpox are more likely to have swollen lymph nodes than people with chickenpox.

The rashes act differently, too. While the chickenpox rash can appear in waves, mpox sores develop at the same time. Chickenpox symptoms — including the rash — tend to get better within two weeks, while it takes two to four weeks for mpox to resolve.

Mpox vs. smallpox

Smallpox and mpox are both part of the Orthopoxvirus genus, so they’re caused by similar but distinct viruses. Thanks to effective vaccines, smallpox was eradicated (is no longer a circulating disease) by 1980. Smallpox was very contagious and spread more easily than mpox. Mpox symptoms are similar to smallpox, but milder.

 

A note from Cleveland Clinic

 

The last few years have been incredibly challenging — the COVID-19 pandemic changed so much about the way we lived and worked. Now, just as we’re starting to ease back into regular life, we’re hearing media stories about mpox as an emerging threat. But mpox is a rare disease. It’s spread through close contact, like kissing and sex, but we’re still learning about how mpox spreads in human

The best way to protect yourself is to get vaccinated if you’re at high risk, avoid contact with people who are infected, wash your hands frequently and wear a face mask in crowded, indoor spaces. Early symptoms of mpox are flu-like and include fever, chills and body aches. After a few days, a rash will begin to develop. See a healthcare provider if you develop symptoms.

(Source: Cleveland Clinic)

Continue Reading

Health

Nigeria Records Mpox Cases Amid Global Health Emergency

Published

on

An undated colorized electron micrograph of mpox virus particles (red) found within an infected cell (brown) cultured in the laboratory, captured at the National Institute of Allergy and Infectious Diseases in Fort Detrick, Maryland. (NIAID via Reuters)

 

ABUJA, NIGERIA —

Barely 48 hours after the World Health Organization declared mpox a global health emergency, Nigeria went on high alert Friday, announcing new mpox cases and raising concerns about the country’s ability to contain the outbreak.

The Nigeria Center for Disease Control and Prevention, or NCDC, said it has recorded 39 cases of mpox so far this year amid a surge in infections across Africa. No deaths have been recorded in Nigeria.

Bayelsa, Cross River, Ogun and Lagos states are the most affected by the outbreak.

Speaking at a news conference, NCDC lead Dr. Olajide Idris said that the nation is ramping up its response to manage the spread of the virus and prevent the disease from being imported.

Mpox is a rare viral zoonotic disease, meaning it is primarily an animal disease that can be transmitted to humans. It is endemic in several African countries, with over 2,800 cases reported across 13 countries this year, claiming more than 500 lives.

Symptoms include fever, body aches, weakness, headaches and rashes.

With a more lethal strain emerging, Idris said that vaccination plans are being considered for high-risk populations.

“The Nigerian government is making effort to make vaccines available to the public, especially for the hotspot areas,” he said. “These vaccines have been shown to have a favorable safety profile. They are not yet in the country, but they are on their way.”

Olayinka Badmus, deputy project director for Global Health Security, Breakthrough Action Nigeria, said the new strain poses a higher risk.

“This particular strain is new, and anything new requires new learning. The things that we have seen related to this particular strain is the fact that it is spreading quite fast, the presenting symptoms — especially the rash — are widespread,” she said, meaning that the rash is all over the body.

“We are also seeing more children affected with mpox compared to the other strains,” Badmus said.

Another cause for concern, she said, is that this strain has “a higher human-to-human transmission at an accelerated rate.”

Idris stressed the need for public awareness in containing the spread and urged people to seek medical attention if they experience symptoms.

“We encourage everybody feeling feverish, muscle pain, sore throat to please visit the nearest health care facility,” he said.

Public health experts are also urging people to adhere to preventive measures such as avoiding contact with potentially infected animals and practicing good hygiene. (VOA)

Continue Reading

Health

Pate Calls for Multi-Sectorial Approach to Combat Infectious Diseases in Nigeria

Published

on

The Coordinating Minister of Health and Social Welfare, Prof. Muhammad Ali Pate, has emphasized the need for a multi-sectorial approach to prevent outbreaks of infectious diseases such as Cholera, Typhoid Fever, and Tuberculosis in Nigeria.

Speaking on Channels Television’s “The Morning Brief” show on Wednesday, Prof. Pate highlighted the importance of addressing the social determinants of health through comprehensive public policies that provide social safety nets for vulnerable and impoverished populations.

“There are many diseases that are socially determined. They largely affect vulnerable and poor populations who live in inadequate housing, with low sanitation, insufficient food, malnutrition, or occupational hazards that expose them to certain disease conditions,” Prof. Pate explained.

He pointed out that tackling population health issues extends beyond biomedical solutions. “To address population health, there is the biomedical aspect, but many diseases go beyond that and are multi-sectorial in their determinants.

At the end of the day, we need to grow our economy and translate that growth into household incomes. We need to build infrastructure to support urbanization, ensuring people have good housing, nutrition, safe spaces, mental health support, and access to affordable health facilities.”

Prof. Pate underscored that health issues are intertwined with various public policies, including housing, transportation, agriculture, environment, youth, and gender. He called for a comprehensive effort from the entire government and society to improve the health and well-being of the population. “We need to address vulnerabilities through social protection mechanisms to ensure safety nets for those left behind.”

In response to the ongoing Cholera outbreak, Prof. Pate assured Nigerians that the Federal Government has mobilized resources to contain its spread. He noted that a technical working group, activated through the Nigeria Centre for Disease Control (NCDC), is supporting states to reduce transmission and treat infected individuals.

“We had anticipated the seasonal outbreak, and months ago, the President approved contingency financing for the NCDC, which has been utilized alongside technical financing. States also have a role to play in releasing their own funding,” Prof. Pate said. He revealed that 31 states and 107 local governments are currently affected, with approximately 1,500 Cholera cases recorded so far.

Addressing the root causes of the outbreak, Prof. Pate stressed the need to eliminate open defecation, which contributes to the contamination of food and water.

“Cholera is a public health crisis exacerbated by contaminated food and water, poor sanitation, developmental challenges, and infrastructure deficits. Open defecation prevalent in many parts of the country is fueling the outbreak,” he stated.

Prof. Pate called for a collective effort from all stakeholders, including citizens and federal, state, and local government administrations, to ensure proper waste management and hygiene sanitation. “It is not only Cholera; other infectious diseases like Typhoid Fever and Tuberculosis also need to be addressed. As we improve physical infrastructure, urbanization, and supporting utilities, we should see a healthier population.”

Continue Reading

Archives

Categories

Meta

Advertisement
Advertisement
Advertisement

Trending